The effect of progesterone and its metabolite 5 alpha-pregnan-3 alpha-ol-20-one on focal epileptic seizures in the cat's visual cortex in vivo.
The acute effects of progesterone and its brain metabolite 5 alpha-pregnan-3 alpha-ol-20-one (3 alpha-OH-DHP) on focal epileptic seizures in the cat's visual cortex was studied in vivo using an unanesthetized cervaux-isolé preparation. This model made it possible to study in parallel the effect of the drugs on ictal activity and synaptic transmission. A dose-dependent increase in seizure threshold was observed after i.v. injections of both 3 alpha-OH-DHP and progesterone, 3 alpha-OH-DHP being about 20 times as potent as the latter. I.v. injections of 3 alpha-OH-DHP 1.0 mg/kg increased the median seizure threshold to 265% of baseline. While 3 alpha-OH-DHP exerted an immediate effect on seizure thresholds, the maximal effect of progesterone was delayed about 20 min. Concerning the mechanisms underlying the antiepileptic effect, three changes occurred within the effective dose range: (1) a small, but significant reduction in the presynaptic nerve volleys, (2) a reduction in the postsynaptic excitatory field potentials in the dorsal lateral geniculate nucleus and cortex, and (3) an enhanced postsynaptic inhibition. Taken together, these observations point to both pre- and postsynaptic effects, supporting the hypothesis of a barbiturate-like mechanism of action of progesterone and its brain metabolites.
Taubøll
E
E
Department of Neurology, Rikshospitalet, National Hospital, University of Oslo, Norway.
Lindström
S
S
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D002540:Cerebral Cortex / Q000502:physiology; D003655:Decerebrate State / Q000503:physiopathology; D004558:Electric Stimulation; D004569:Electroencephalography / Q000187:drug effects; D004828:Epilepsies, Partial / Q000473:pathology / Q000517:prevention & control*; D005071:Evoked Potentials / Q000187:drug effects; D005260:Female; D005829:Geniculate Bodies / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D007275:Injections, Intravenous; D011092:Polyethylene Glycols / Q000494:pharmacology; D011280:Pregnanolone / Q000494:pharmacology*; D011374:Progesterone / Q000494:pharmacology*; D014793:Visual Cortex / Q000473:pathology*
D000927:Anticonvulsants; D011092:Polyethylene Glycols; D011374:Progesterone; D011280:Pregnanolone; C018557:glycofurol